Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (16)

2023

  1. Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. 100-105

  2. Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies

    Expert Review of Hematology, Vol. 16, Núm. 3, pp. 213-226

2022

  1. Iniciativas para la mejora del manejo de los pacientes con coagulopatías congénitas por parte de farmacia hospitalaria

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 109-115

2021

  1. Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 5, pp. 268-272

  2. Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E66-E71

2020

  1. Registry of patients with congenital bleeding disorders and COVID-19 in Madrid

    Haemophilia, Vol. 26, Núm. 5, pp. 773-778

2019

  1. Accelerating recovery from acute hemarthrosis in patients with hemophilia: The role of joint aspiration

    Blood Coagulation and Fibrinolysis, Vol. 30, Núm. 3, pp. 111-119

2016

  1. Multimodal blood loss prevention approach including intra-articular tranexamic acid in primary total knee arthroplasty for patients with severe haemophilia A

    Haemophilia

  2. Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25 years and its potential association with bleeding episodes

    Thrombosis Research, Vol. 143, pp. 22-27

2014

  1. Adequacy of clotting factor in haemophilic patients underwent surgery based on analytical parameters and plasmatic clearance

    Atencion Farmaceutica, Vol. 16, Núm. 2, pp. 110-116

  2. Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: Results from a retrospective cohort study

    Thrombosis Research, Vol. 133, Núm. 6, pp. 1045-1051

2013

  1. Lipid profile disorder in HIV infected patients treated with lopinavir/ritonavir and its relation with adherence To treatment

    Atencion Farmaceutica, Vol. 15, Núm. 3, pp. 171-177

  2. Study of costs of inhibitor development in patients with severe hemophilia A in Spain

    Pharmacoeconomics - Spanish Research Articles, Vol. 10, Núm. 2, pp. 69-78

  3. Trastuzumab induced cardiotoxicity in patients with HER2+ breast cancer

    Atencion Farmaceutica, Vol. 15, Núm. 4, pp. 261-267

2011

  1. Trastorno de la agregación plaquetaria debido a amitriptilina

    Farmacia Hospitalaria

2004

  1. Surgery in haemophilic patients with inhibitor: 20 years of experience

    Haemophilia, Supplement, Vol. 10, Núm. 2, pp. 30-40